Director Hta & Decision Science

Johnson & Johnson Johnson & Johnson · Pharma · Raritan, NJ +1

This role focuses on Health Technology Assessment & Decision Science within Johnson & Johnson's Innovative Medicine division. The Director will inform internal decision-making on clinical development programs, evidence generation, and market access strategies by translating HTA agency and payer insights into actionable inputs. The role also involves leading early HTA agency advice activities, contributing to EU Joint Clinical Assessments, and providing market access reviews for clinical trial designs. While the role mentions leveraging generative AI, its core function is product strategy and market access within healthcare, not direct AI/ML development.

What you'd actually do

  1. translating HTA agency, payer and health system insights and benchmarks for key markets (incl. US, Japan, EU G4, UK) into actionable decision‑science inputs for development programs and access & evidence generation strategies. Leverage generative AI to enable and enhance internal decision making.
  2. leading, supporting and delivering early HTA agency advice activities, including individual agency and multi-agency procedures (e.g. EU Joint Scientific Consultations) across the portfolio, in collaboration with product teams.
  3. Represent HTA & DS in EU Joint Clinical Assessment (EU JCA) dossier teams, shaping and contributing to delivering PICO strategy and informing dossier development strategy.
  4. Provide Market Access technical and scientific review at Protocol Review Committee to ensure patient‑ and payer‑relevant study designs.
  5. Contribute to and deliver HTA capability development, internal briefings, external positioning documents, and external thought leadership.

Skills

Required

  • Advanced degree (MSc, PhD, PharmD, MD, or equivalent) in a relevant discipline (eg., Epidemiology, Biostatistics, (health) Economics, HTA, Medicine, Public Health).
  • At least 7 years of experience in HTA, market access, evidence generation, or related fields, in a pharmaceutical organization and/or external agency.
  • Strong R&D acumen
  • Experience working across multiple therapeutic areas (ideally including one or more of Oncology, Immunology, Neuroscience, Cardiopulmonary) and phase 2, 3 development and launch phases.
  • Strong understanding of international health care, HTA, payer and regulatory environments, with one or more of Europe, the US, and Japan preferred.

Nice to have

  • Agility Jumps
  • Commercial Awareness
  • Competitive Landscape Analysis
  • Cross-Functional Collaboration
  • Customer Intelligence
  • Global Market
  • Go-to-Market Strategies
  • Health Economics
  • Health Intelligence
  • Market Knowledge
  • Market Opportunity Assessment
  • Mentorship
  • Pricing Strategies
  • Regulatory Compliance
  • Strategic Change
  • Tactical Planning
  • Technical Credibility

What the JD emphasized

  • Leverage generative AI to enable and enhance internal decision making.